Navigation

Published technology appraisals

This table lists published NICE technology appraisals. The list can be sorted by title (alphabetically), issue date and review date. You can also:

  • click the appraisal title for full details
  • click a column heading to sort the list by that column

Please note that the 'review date' is not the date when a review of it the appraisal starts, but the date NICE consults on a proposal for reviewing it. There is no guarantee that at the review date, a review will be undertaken. Appraisals which have been considered for review and where the decision has been not to carry out a review at this time are listed in static technology appraisals.

More information on the published appraisals list.

For technology appraisal guidance organised by category, use Find guidance in the main header area above.

Searching for specific technology appraisal guidance?

Published appraisals

Results 41-60 of 308

Ref Title Date Issued Review
TA38 Asthma (older children) - inhaler devices (TA38) Mar 2002 TBC
TA34 Breast cancer - trastuzumab (TA34) Mar 2002 TBC
TA33 Colorectal cancer (advanced) - irinotecan, oxaliplatin & raltitrexed (TA33) (replaced by TA93) (withdrawn) Mar 2002 TBC
TA40 Crohn's disease - infliximab (TA40) (replaced by TA187) Apr 2002 May 2005
TA43 Schizophrenia - atypical antipsychotics (TA43) (replaced by CG82) Jun 2002 TBC
TA54 Breast cancer - vinorelbine (TA54) (replaced by CG81) Dec 2002 TBC
TA51 Depression and anxiety - computerised cognitive behaviour therapy (CCBT) (TA51) (replaced by TA97) (withdrawn) Oct 2002 TBC
TA42 Growth hormone deficiency (children) - human growth hormone (TA42) (replaced by TA188) May 2002 Jun 2005
TA46 Obesity (morbid) - surgery (TA46) (replaced by CG43) (withdrawn) Jul 2002 TBC
TA49 Central venous catheters - ultrasound locating devices (TA49) Sep 2002 TBC
TA48 Renal failure - home versus hospital haemodialysis (TA48) Sep 2002 TBC
TA58 Flu treatment - zanamivir (review), amantadine and oseltamivir (TA58) (replaced by TA168) (withdrawn) Feb 2003 TBC
TA52 Myocardial infarction - thrombolysis (TA52) Oct 2002 TBC
TA53 Diabetes (types 1 and 2) - long acting insulin analogues (TA53) Dec 2002 Nov 2005
TA59 Electroconvulsive therapy (ECT) (TA59) Apr 2003 TBC
TA62 Breast cancer - capecitabine (TA62) (replaced by CG81) May 2003 TBC
TA61 Colorectal cancer - capecitabine and tegafur uracil (TA61) May 2003 TBC
TA60 Diabetes (types 1 and 2) - patient education models (TA60) Apr 2003 Feb 2006
TA56 Stress incontinence - tension-free vaginal tape (TA56) (replaced by CG171) (withdrawn) Feb 2003 TBC
TA57 Diabetes (type 1) - insulin pump therapy (TA57) (replaced by TA151) (withdrawn) Feb 2003 TBC

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.